Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20 |
Resumo: | Mephedrone is a semisynthetic derivative of cathinone used as a drug of abuse. Similar to amphetamine, both in chemical structure and associated symptoms, has gained popularity since 2007 and it is currently the sixth most popular drug among United Kingdom users. It can be easily purchased on the Internet or smart shops and it is more advantageous than ecstasy, given its higher purity and lower price. Mephedrone is advertised as a fertilizer for plants or bath salts, and yet it has never been proved as such. This article aims to review the state-of-the-art literature of mephedrone, particularly its chemical structure, forms of presentation, pharmacokinetics, pharmacodynamics, acute intoxications, diagnosis and intoxications therapy. Mephedrone is mainly sought for the following symptoms: euphoria, social disinhibition, empathy, and increased libido. However, its use is associated with several adverse effects on cardiovascular, gastrointestinal, neurological, psychiatric and genitourinary systems, among others. There are also reported cases of consumers who have developed tolerance and dependence after a regular consumption of mephedrone. Several deaths in the United Kingdom have been confirmed as being directly related to the consumption of mephedrone. Currently this drug is legally controlled in many countries, but little is known about its pharmacokinetics and pharmacodynamics. Most comes only from users and health professional’s reports and internet surveys. Recently, the Portuguese Law 13/2012, 26 of march, included mephedrone in the list of controlled substances, and therefore it is important to better understand this xenobiotic. |
id |
RCAP_52ae1cbb79c900991f5efcf20027d94e |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/20 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic IssuesMefedrona, a Nova Droga de Abuso: Farmacocinética, Farmacodinâmica e Implicações Clínicas e ForensesMephedrone is a semisynthetic derivative of cathinone used as a drug of abuse. Similar to amphetamine, both in chemical structure and associated symptoms, has gained popularity since 2007 and it is currently the sixth most popular drug among United Kingdom users. It can be easily purchased on the Internet or smart shops and it is more advantageous than ecstasy, given its higher purity and lower price. Mephedrone is advertised as a fertilizer for plants or bath salts, and yet it has never been proved as such. This article aims to review the state-of-the-art literature of mephedrone, particularly its chemical structure, forms of presentation, pharmacokinetics, pharmacodynamics, acute intoxications, diagnosis and intoxications therapy. Mephedrone is mainly sought for the following symptoms: euphoria, social disinhibition, empathy, and increased libido. However, its use is associated with several adverse effects on cardiovascular, gastrointestinal, neurological, psychiatric and genitourinary systems, among others. There are also reported cases of consumers who have developed tolerance and dependence after a regular consumption of mephedrone. Several deaths in the United Kingdom have been confirmed as being directly related to the consumption of mephedrone. Currently this drug is legally controlled in many countries, but little is known about its pharmacokinetics and pharmacodynamics. Most comes only from users and health professional’s reports and internet surveys. Recently, the Portuguese Law 13/2012, 26 of march, included mephedrone in the list of controlled substances, and therefore it is important to better understand this xenobiotic.A mefedrona é um derivado semissintético da catinona usada como droga de abuso. Semelhante às anfetaminas, quer na estrutura química, quer nos sintomas que desencadeia, tem ganho popularidade desde 2007, sendo a sexta droga mais popular entre consumidores no Reino Unido. Pode ser facilmente comprada na internet ou em smart shops, mostrando-se vantajosa face à ecstasy, dada a sua maior pureza e o preço mais baixo. É publicitada como fertilizante para plantas e sais de banho, apesar de não estar provada a sua eficácia como tal. O presente artigo tem como objetivo proceder à revisão do estado da arte relativa à mefedrona, nomeadamente no que diz respeito à sua estrutura química, formas de apresentação, farmacocinética, farmacodinâmica, intoxicação aguda, diagnóstico e terapêutica das intoxicações. Os principais sintomas pelos quais a mefedrona é procurada são a euforia, desinibição social, empatia e aumento da libido. No entanto, o seu consumo está associado a vários efeitos adversos a nível cardiovascular, gastrointestinal, neurológico, psiquiátrico, geniturinário, entre outros. Existem também casos descritos de consumidores que desenvolveram tolerância e dependência após um consumo regular de mefedrona. No Reino Unido foram já confirmadas várias mortes diretamente relacionadas com o consumo de mefedrona. Atualmente esta droga está legalmente controlada em vários países, porém ainda pouco se sabe acerca da sua farmacocinética e farmacodinâmica. Os dados existentes sobre os efeitos da mefedrona provêm apenas de relatos de consumidores, dos profissionais de saúde que trabalham nos serviços de emergência médica e de sondagens feitas através da internet. Recentemente, Portugal, através da Lei n.º 13/2012, de 26 de Março, incluiu a mefedrona na lista de substâncias controladas, pelo que se justifica conhecer melhor este xenobiótico.Ordem dos Médicos2012-06-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20oai:ojs.www.actamedicaportuguesa.com:article/20Acta Médica Portuguesa; Vol. 25 No. 2 (2012): March-April; 111-117Acta Médica Portuguesa; Vol. 25 N.º 2 (2012): Março-Abril; 111-1171646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20/30Ribeiro, EmanuelMagalhães, TeresaDinis-Oliveira, Ricardo Jorgeinfo:eu-repo/semantics/openAccess2022-12-20T10:55:41Zoai:ojs.www.actamedicaportuguesa.com:article/20Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:20.700011Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues Mefedrona, a Nova Droga de Abuso: Farmacocinética, Farmacodinâmica e Implicações Clínicas e Forenses |
title |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
spellingShingle |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues Ribeiro, Emanuel |
title_short |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
title_full |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
title_fullStr |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
title_full_unstemmed |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
title_sort |
Mephedrone (“Meow Meow”), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues |
author |
Ribeiro, Emanuel |
author_facet |
Ribeiro, Emanuel Magalhães, Teresa Dinis-Oliveira, Ricardo Jorge |
author_role |
author |
author2 |
Magalhães, Teresa Dinis-Oliveira, Ricardo Jorge |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Ribeiro, Emanuel Magalhães, Teresa Dinis-Oliveira, Ricardo Jorge |
description |
Mephedrone is a semisynthetic derivative of cathinone used as a drug of abuse. Similar to amphetamine, both in chemical structure and associated symptoms, has gained popularity since 2007 and it is currently the sixth most popular drug among United Kingdom users. It can be easily purchased on the Internet or smart shops and it is more advantageous than ecstasy, given its higher purity and lower price. Mephedrone is advertised as a fertilizer for plants or bath salts, and yet it has never been proved as such. This article aims to review the state-of-the-art literature of mephedrone, particularly its chemical structure, forms of presentation, pharmacokinetics, pharmacodynamics, acute intoxications, diagnosis and intoxications therapy. Mephedrone is mainly sought for the following symptoms: euphoria, social disinhibition, empathy, and increased libido. However, its use is associated with several adverse effects on cardiovascular, gastrointestinal, neurological, psychiatric and genitourinary systems, among others. There are also reported cases of consumers who have developed tolerance and dependence after a regular consumption of mephedrone. Several deaths in the United Kingdom have been confirmed as being directly related to the consumption of mephedrone. Currently this drug is legally controlled in many countries, but little is known about its pharmacokinetics and pharmacodynamics. Most comes only from users and health professional’s reports and internet surveys. Recently, the Portuguese Law 13/2012, 26 of march, included mephedrone in the list of controlled substances, and therefore it is important to better understand this xenobiotic. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-06-25 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20 oai:ojs.www.actamedicaportuguesa.com:article/20 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/20 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20/30 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 25 No. 2 (2012): March-April; 111-117 Acta Médica Portuguesa; Vol. 25 N.º 2 (2012): Março-Abril; 111-117 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130617677348864 |